| Autor: |
A Burak-Leipuner, F Higuera-de la Tijera, A Servín-Caamaño, J Romero-Bermúdez, L Ceceña-Martínez, F García-Gorrosquieta, N Uribe-Rivera, P Alagón-Fernández del Campo, F Vargas-Duran, C Hinojosa-Segura, D Montemira-Orozco, JL Pérez-Hernández |
| Jazyk: |
angličtina |
| Rok vydání: |
2022 |
| Předmět: |
|
| Zdroj: |
Annals of Hepatology, Vol 27, Iss , Pp 100836- (2022) |
| Druh dokumentu: |
article |
| ISSN: |
1665-2681 |
| DOI: |
10.1016/j.aohep.2022.100836 |
| Popis: |
Introduction and Objectives: Diabetes is a high-risk condition for the progression of metabolic fatty liver disease (MAFLD). The FAST index combines the result of transition elastography (Fibroscan®) and AST levels and is used to predict the risk of suffering from non-alcoholic steatohepatitis (NASH) with a high risk of progression (NAS >4, F>2). This study aimed to know what proportion of diabetic patients is at risk of suffering from high-risk NASH according to the FAST® index. Materials and Methods: Observational, transversal study to estimate prevalence. Diabetic patients who agreed to perform Fibroscan® and liver biochemical profile were included, and the FAST® index was calculated ( |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
